The second phase of human clinical trials of a general cancer drug is currently underway. This is a one-month clinical trial.

The one-month clinical trial has now only been conducted for two days. However, preliminary results can already be seen from the two-day clinical trial.

No matter what kind of cancer patients are, the two days of medicine has already played a certain role in their bodies, and some effects can be seen from it.

Patients in the late stages of cancer are the most sensitive group of people, because people at this stage often have more than one disease, and various complications follow.

Precisely because they are the most sensitive people, when their bodies improve, they are also the ones who can best feel the changes.

Almost on the next day, they felt the changes in their bodies, which were for the better, and this change was extremely obvious.

When they were conducting the test on the second day, some people posted their personal physical conditions through Weibo and Moments, and shared them with family, relatives and friends.

"I'm very grateful to Xingchen Pharmaceutical. They gave me hope. After taking their medicine, I feel much better. I look forward to seeing everyone see the new me in a month."

"After only taking the medicine for one day, I feel much better. Xingchen Pharmaceutical has given me hope of curing cancer."

"This is a comparison of data between taking drugs and not taking drugs. I will release a data every day for record use. I look forward to it."

"In one day, I saw the hope of curing cancer. Even if it fails, I hope everyone will not blame Xingchen Pharmaceutical too much. This is a company that strives for cancer patients to have hope."

On this day, almost everyone shared in their circle of friends how they felt about doing the second phase of human clinical trials at Xingchen Pharmaceutical.

More than 7,000 cancer patients from all over the country shared their feelings.

A hot search about "Xingchen Pharmaceutical, a general drug for cancer treatment" quickly appeared on the 24-hour hot search list.

For these more than 7,000 terminal cancer patients, their relatives and friends basically knew their status. When they saw them saying that they saw hope of survival in Xingchen Pharmaceutical, they couldn't help but cheer for them in their hearts.

Those who are more concerned about the efficacy of Xingchen Pharmaceutical's general cancer drug are those who are about to participate in the third phase of human clinical trials. Seeing that people in the second phase have improved after taking the drug, they seem to have seen their own hope.

Not only them, more cancer patients are paying attention to the news about Xingchen Pharmaceutical’s general cancer drug.

"Xingchen Pharmaceutical 666 is indeed produced by Xingchen, and it must be a high-quality product. Whether it is a technological product or a pharmaceutical product, it is first-class. I seem to have seen the rise of Xingchen Beverage's 'strengthening' drink."

"It's really effective. Isn't it just fraud? Nowadays, many companies deliberately create fake news to deceive people."

"How could a subsidiary of Xingchen Technology commit fraud? Moreover, these people's news is not the information released by Xingchen Pharmaceutical itself, but the information released by the people participating in the clinical trial. Many people can confirm the information of these people, and it cannot be false.

of."

"That's right, how could it be fake? I just hope Xingchen Pharmaceutical can be more powerful now. After the second phase is completed, I can slap those who say they are committing fraud."

"Brothers above, are you correct? I was wrong. Don't slap me in the face. I also hope it is true because my own family has cancer. I also hope that this medicine can really cure cancer. In this way, I

There is no need to lose my relatives."

"I support Xingchen Pharmaceutical. As long as this drug can be successfully launched, I will definitely support it."

"Support 1."

"Support 10086."

No matter how hot the Internet is about the general cancer drug produced by Xingchen Pharmaceutical, Xingchen Pharmaceutical has not made any response to the information on the Internet, and the second phase of human clinical trials is proceeding in an orderly manner.

Although Xingchen Pharmaceutical did not release any official news, it did not prevent patients from revealing their condition.

Hou Yaolin has sufficient information about this drug, and the information released by patients is information about its improvement, which can be regarded as a disguised advertisement for Xingchen Pharmaceutical.

Since it became a hot topic, the topic of universal cancer drugs has not been in the top ten.

Star-related topics account for half of the 24-hour hot topics.

Netizens have become accustomed to this over the past month.

Whether it is Xingchen Technology, Xingchen Pharmaceutical, or Xingchen Beverage, the information given by each company is eye-catching. Even if it is not directly named after Xingchen Group Company, it is still related to Xingchen Group Company.

Yes, you read that right. With Liu Mingyu’s permission, Liu Mingyu established Xingchen Group with more and more subsidiaries.

Xingchen Group can be said to have transformed from an ordinary company to a group company at the fastest speed, breaking various records.

There is nothing we can do about this. As more and more companies are acquired, establishing a group company is the best choice.

With elites like Zhao Qingsong and others around, he didn't have to do anything and quickly established a group company headed by Xingchen Technology.

Currently, there are three main subsidiaries: Xingchen Technology, Xingchen Pharmaceutical, and Xingchen Beverage.

The valuation of every company is very astonishing, but the most astonishing one right now is the valuation of Xingchen Technology. Unfortunately, Xingchen Technology is not listed, and many venture capital companies can only make evaluations based on current data.

This assessment is inaccurate because the information they can obtain is too little, but even so, the valuation of Xingchen Group has reached the trillion level in the venture capital industry.

Yes, you heard me right, it has reached the trillion level. With this level of financing, even the top investment companies have taken a fancy to Xingchen Group, because they know that as long as they get on this line, they will make a profit without losing money.

Xingchen Group has risen too fast. Before they could do a good valuation, Xingchen Group released a product that was ahead of its time, forcing them to re-evaluate.

Liu Mingyu refused investment from too many people. Liu Mingyu did not want others to get involved in the company in his hands.

For some key leaders of the company, he would rather increase their rewards and give them more money than give them his own shares.

If there are more shareholders, some information needs to be disclosed to those shareholders.

Liu Mingyu has too much information to hide, so keeping the company firmly in his own hands is the best choice.

What's more, with a zombie conversion factory, you can create zombies that are loyal to you, which is the best choice.

Not only Xingchen Pharmaceutical is running in an orderly manner, but Xingchen Technology and Xingchen Beverage are also running in an orderly manner. The zombies headed by Zhao Qingsong manage the company in an orderly manner.
Chapter completed!